Osteopoietin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameOsteopoietin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs
Mechanisms of ActionOsteogenesis stimulants
TargetsUpdating
Therapy Area/IndicationsOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMetra Biosystems Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMetra Biosystems Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis, Postmenopausal

Other Information

ATC CodeN/A
Related LinksN/A